Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 5;10(3):7744.
doi: 10.4081/idr.2018.7744. eCollection 2018 Nov 6.

Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece

Affiliations

Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece

Eleni Vergadi et al. Infect Dis Rep. .

Abstract

Group B streptococcus (GBS) remains a leading cause of neonatal disease. However, GBS rates and prevention strategies vary considerably worldwide. Herein, we investigated the burden and epidemiological trends of neonatal GBS infections in our area (Greece) over the last two decades. We conducted a multicenter retrospective study that includes all cases of culture-proven GBS disease in infants <90 days old in the last 22 years. Neonatal GBS incidence was 0.17/1000 live births (95%CI: 0.11-0.21). A significant increase was noted during the second decade (0.23 vs 0.10/1000, P<0.05). Late onset disease (LOD) significantly increased during the second decade (0.08 vs 0.02, P<0.05). Infants in the LOD group had a higher risk of meningitis (RR 1.8, 95%CI: 1.23-2.71). Long-term neurological sequelae were reported in 42.8% of meningitis cases. The mortality rate was 8%. The incidence of neonatal GBS disease in our area is among the lowest reported, but an increase was noted the last decade mainly due a rise in the LOD. The burden of LOD, the mortality and long-term disability are still substantial, thus effective prevention strategies - including maternal vaccination for neonatal GBS - are needed.

Keywords: Group B streptococcus; early onset; incidence; intrapartum prophylaxis; late onset; neonatal infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: the authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Annual incidence of Group B Streptococcus (GBS) infections in infants less than 90 days of age in Crete, Greece. The rate of all cases of GBS are depicted (circles, black line) as well as the incidence of early onset GBS disease (EOD, white bars) and late onset GBS disease (LOD, gray bars) per each year.
Figure 2.
Figure 2.
Group B Streptococcus (GBS) rates of early onset disease (EOD), late onset disease (LOD) and total rates of GBS invasive disease in infants less than 90 years old between the decades 1995-2005 and 2006-2016 in Crete, Greece. Boxes show 5–95 percentiles, horizontal line represents median, and whiskers represent minimum and maximum. *P<0.05.
Figure 3.
Figure 3.
Percentage of Group B Streptococcus (GBS) invasive disease (sepsis and meningitis) in infants born to Crete the last 22 years. Data are categorized to early onset (0-6 days) or late onset (7-89 days) infections.

References

    1. Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130:e8-15. - PubMed
    1. Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36. - PubMed
    1. Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000;21:473-83. - PubMed
    1. Ecker KL, Donohue PK, Kim KS, et al. The impact of group B Streptococcus prophylaxis on early onset neonatal infections. J Neonatal Perinatal Med 2013;6:37-44. - PubMed
    1. Matsubara K, Hoshina K, Kondo M, et al. Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015. Infection 2017;45:449-58. - PubMed

LinkOut - more resources